Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2026-05-10 @ 2:54 AM
Study NCT ID:
NCT06834035
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2025-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
Sponsor:
M. Peter Marinkovich
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Epidermolysis Bullosa | View |
| None | Epidermolysis Bullosa Acquisita | View |
| None | Dystrophic Epidermolysis Bullosa | View |
| None | Recessive Dystrophic Epidermolysis Bullosa | View |
| None | Collagen 7 | View |
| None | C7 | View |
| None | Col7 | View |
| None | EB | View |
| None | EBA | View |
| None | DEB | View |
| None | RDEB | View |
| None | Antibodies | View |
| None | Collagen VII | View |
| None | IV IgG | View |
| None | IgG | View |
| None | IVIgG | View |
| None | C7 Antibodies | View |
| None | Collagen 7 Antibodies | View |
| None | Collagen VII Antibodies | View |
| None | Vyjuvek | View |
| None | B-VEC | View |